📰 Basic Research News
Page 17 - Basic Research News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Basic Research. Real-time updates on events, politics, business and more.
June 3, 2022
Chinas deputy permanent representative to the United Nations, Dai Bing, rejected Western countries fabrications about the situation in Chinas Xinjiang Uygur Autonomous Region on Thursday.
June 2, 2022
TMS members are uniquely qualified to offer useful perspectives to government leaders on issues of public policy pertaining to minerals, metals, and materials.
May 26, 2022
LAKE OSWEGO – More than 250 community members gathered at Mary’s Woods to celebrate residents John Hammerstad and Jay Nutt, retired medical doctors,
May 20, 2022
The COVID-19 restrictions have impacted people's lifestyles in all spheres (social, psychological, political, economic and others). This study explored which factors affected the level of anxiety during the time of the first wave of COVID-19 and subsequent quarantine in a substantial proportion of 23 countries, included in this study. The data was collected from May to August 2020 (5 June 2020). The sample included 15,375 participants from 23 countries: (seven from Europe: Belarus, Bulgaria,...
May 15, 2022
Greater government funding for new tech and taxing use of foreign know-how among suggestions from Tsinghua economists.
May 13, 2022
The DoD announced today $14.6 million in DEPSCoR awards to 23 collaborative teams following two FY2021 competitions. DEPSCoR is a capacity-building program that is designed to strengthen the basic research infrastructure at institutions of higher education in under-utilized states/territories.
April 29, 2022
Expands library of proprietary cannabinoid analogs for pharma R&DResearch collaboration initiated to screen analogs for therapeutic uses VANCOUVER,...
April 24, 2022
Astrophysicist asks whether Chinese people can really be confident if their textbooks are based on work from the West.
April 21, 2022
Ampligen has demonstrated in pre-clinical and now human clinical studies a potential to enhance efficacy of PD-1 and/or PD-L1 checkpoint inhibitors ...
April 21, 2022
Ampligen has demonstrated in pre-clinical and now human clinical studies a potential to enhance efficacy of PD-1 and/or PD-L1 checkpoint inhibitors Ampligen's anti-tumor potential is demonstrated with